PILOTTO, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 11.370
AS - Asia 4.302
EU - Europa 3.337
SA - Sud America 1.235
AF - Africa 192
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.469
Nazione #
US - Stati Uniti d'America 11.196
SG - Singapore 1.806
BR - Brasile 970
IT - Italia 904
CN - Cina 856
HK - Hong Kong 563
SE - Svezia 387
RU - Federazione Russa 354
FR - Francia 342
FI - Finlandia 327
VN - Vietnam 310
DE - Germania 298
GB - Regno Unito 191
UA - Ucraina 165
IN - India 131
BD - Bangladesh 114
ID - Indonesia 98
NL - Olanda 96
AR - Argentina 95
CA - Canada 86
IQ - Iraq 57
MX - Messico 56
TR - Turchia 52
PK - Pakistan 45
ZA - Sudafrica 43
ES - Italia 41
MA - Marocco 40
AT - Austria 39
EC - Ecuador 39
PL - Polonia 39
JP - Giappone 35
SA - Arabia Saudita 35
IE - Irlanda 33
VE - Venezuela 30
BE - Belgio 28
AU - Australia 27
CO - Colombia 26
CL - Cile 25
UZ - Uzbekistan 25
TN - Tunisia 21
KE - Kenya 19
PH - Filippine 19
PE - Perù 18
KR - Corea 15
MY - Malesia 15
PY - Paraguay 14
CI - Costa d'Avorio 13
AE - Emirati Arabi Uniti 12
NP - Nepal 12
CH - Svizzera 11
ET - Etiopia 11
JO - Giordania 11
DZ - Algeria 10
EG - Egitto 10
TH - Thailandia 10
BO - Bolivia 9
IL - Israele 9
IR - Iran 9
LT - Lituania 9
SN - Senegal 9
JM - Giamaica 8
OM - Oman 8
PS - Palestinian Territory 8
TW - Taiwan 8
AZ - Azerbaigian 7
BG - Bulgaria 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
AL - Albania 6
CR - Costa Rica 6
RS - Serbia 6
KG - Kirghizistan 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
AO - Angola 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
BH - Bahrain 3
EE - Estonia 3
GR - Grecia 3
LI - Liechtenstein 3
LY - Libia 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
QA - Qatar 3
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
LU - Lussemburgo 2
MN - Mongolia 2
Totale 20.441
Città #
Fairfield 1.371
Ashburn 1.180
Singapore 962
Woodbridge 921
Houston 708
Chandler 659
San Jose 597
Seattle 593
Hong Kong 549
Cambridge 543
Wilmington 451
Ann Arbor 357
Jacksonville 345
Nyköping 341
Beijing 268
Dallas 231
Helsinki 229
Lauterbourg 174
New York 170
Lawrence 151
Roxbury 151
Los Angeles 131
Nanjing 114
Council Bluffs 113
Des Moines 108
Ho Chi Minh City 91
Milan 73
Santa Clara 73
San Diego 71
São Paulo 71
Boardman 68
Jakarta 68
Bari 67
Dearborn 67
Hanoi 64
Munich 58
Dong Ket 53
Brooklyn 52
Paris 48
Falkenstein 47
Chicago 43
London 43
Princeton 43
Rio de Janeiro 41
Buffalo 40
Inglewood 40
Columbus 38
Taranto 38
Rome 36
Nuremberg 33
Dublin 32
The Dalles 32
Washington 32
Moscow 31
Genoa 28
Ostuni 28
Tokyo 27
Redwood City 26
Warsaw 26
Brussels 25
Shenyang 25
Frankfurt am Main 23
Nanchang 23
Ruvo Di Puglia 22
Baghdad 21
Porto Alegre 21
Pune 21
Strasbourg 21
Sydney 21
Belo Horizonte 20
San Francisco 20
Tashkent 20
Toronto 20
Jiaxing 19
Montreal 19
Orem 18
Turin 18
Mexico City 17
Atlanta 16
Boston 16
Denver 16
Jeddah 16
Nairobi 16
Phoenix 16
Quito 16
Hebei 15
Johannesburg 15
Amsterdam 14
Lahore 14
Manchester 14
Vienna 14
Abidjan 13
Brasília 13
Casablanca 13
Changsha 13
Guayaquil 13
Las Vegas 13
Chennai 12
Falls Church 12
Guangzhou 12
Totale 13.751
Nome #
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 501
Development of a smart post-hospitalization facility for older people by using domotics, robotics, and automated tele-monitoring 237
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 235
A multidimensional approach to frailty in older people 201
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 200
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 196
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 188
Validation of a Brief Form of the Self-Administered Multidimensional Prognostic Index: The SELFY-BRIEF-MPI Project 184
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 184
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 182
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 175
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 173
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 173
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 173
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 171
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 171
Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis 168
A New Computer-Based Tool to Reduce Potentially Inappropriate Prescriptions in Hospitalized Geriatric Patients 167
Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder 165
Paraplegia due to Anterior Spinal Artery Stroke: Rehabilitative Program on Lower Extremity Weakness and Locomotor Function 164
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 163
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 159
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 158
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 158
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 158
The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) 158
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 156
Robotic balance assessment in community-dwelling older people with different grades of impairment of physical performance 155
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 153
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 147
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 145
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 144
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 144
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 142
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 141
Frailty and the gut 141
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 141
Agreement of a short form of the self-administered multidimensional prognostic index (SELFY-MPI-SF): A useful tool for the self-assessment of frailty in community-dwelling older people 140
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 139
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 139
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 138
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 137
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 137
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 136
Cognitive frailty: Predementia syndrome and vascular risk factors 135
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 135
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 135
Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies 134
Nutrition, frailty, and Alzheimer's disease. 133
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 133
Vascular risk factors, alcohol intake, and cognitive decline 132
Using the Multidimensional Prognostic Index to Predict Clinical Outcomes of Hospitalized Older Persons: A Prospective, Multicenter, International Study 132
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 129
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 129
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 128
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 128
Robot-based assessment of sitting and standing balance: Preliminary results in Parkinson's disease 128
The Multidimensional Prognostic Index Predicts in-hospital length of stay in older patients: A multicentre prospective study 127
Dietary unsaturated fatty acids and risk of mild cognitive impairment 126
Enteral tube feeding and mortality in hospitalized older patients: A multicenter longitudinal study 125
A multidimensional approach to older patients during COVID-19 pandemic: a position paper of the Special Interest Group on Comprehensive Geriatric Assessment of the European Geriatric Medicine Society (EuGMS) 123
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 123
The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study 122
. Mediterranean diet in predementia and dementia syndromes.REview 121
The Multidimensional Prognostic Index in general practice: One-year follow-up study 121
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease 119
The prognostic significance of geriatric syndromes and resources 119
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 118
Effects of oral amino acid supplementation on Multidimensional Prognostic Index in hospitalized older patients: a multicenter randomized, double-blind, placebo-controlled pilot study 118
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. 116
Oral health indicators and bone mineral density disorders in older age: A systematic review 115
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 115
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 115
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. 114
Management of beta-thalassemia-associated osteoporosis 114
Diet and Alzheimer's disease risk factors or prevention: the current evidence 113
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 113
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia 113
Current epidemiological approaches to the metabolic-cognitive syndrome. 110
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease 110
Apolipoprotein E, dementia, and human longevity 109
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 109
Validation of Abbreviated Form of the Multidimensional Prognostic Index (MPI): The BRIEF-MPI Project 108
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients 108
Mediterranean diet in predementia and dementia syndromes 108
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study 108
Development and implementation of multicomponent homecare interventions for multimorbid and frail older people based on Information and Communication Technologies: The MULTIPLAT_AGE project 108
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 107
Evaluation design of effichronic: The chronic disease self-management programme (CDSMP) intervention for citizens with a low socioeconomic position 107
Urological-Geriatric Integrated Diagnostic-Therapeutic Pathway for elderly patients with urologic diseases 107
APOE and Alzheimer disease: a major gene with semi-dominant inheritance 106
Reply to Letter to the Editor “Polypharmacy in elderly people with diabetes admitted to hospital” 106
Lipoproteins, vascular-related genetic factors, and human longevity 105
Dietary patterns and protection against Alzheimer disease and cognitive decline 105
Different models of frailty in predementia and dementia syndromes. 105
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease 105
Comprehensive Geriatric Assessment 105
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease 104
Cerebral vasoreactivity and intima-media thickness in Down syndrome: A case-control study 104
Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project 103
Totale 14.085
Categoria #
all - tutte 81.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 0 0 141
2021/20221.026 46 65 7 29 60 107 50 46 78 78 164 296
2022/20231.805 246 172 126 157 170 232 33 246 287 22 76 38
2023/2024703 57 105 53 49 54 173 27 46 21 33 17 68
2024/20253.291 83 57 262 142 91 248 357 260 177 201 488 925
2025/20267.175 956 346 546 815 768 517 990 322 806 710 387 12
Totale 21.027